177 related articles for article (PubMed ID: 6988274)
21. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
Wilson RM; Douglas CA; Tattersall RB; Reeves WG
Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477
[TBL] [Abstract][Full Text] [Related]
22. The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides.
Kitabchi AE
J Clin Invest; 1970 May; 49(5):979-87. PubMed ID: 5309725
[TBL] [Abstract][Full Text] [Related]
23. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
[TBL] [Abstract][Full Text] [Related]
24. Elevated circulating proinsulin levels in insulin-requiring diabetic patients.
Block MB; Mako M; Steiner DF; Rubenstein AH
J Lab Clin Med; 1971 Nov; 78(5):811-2. PubMed ID: 5316079
[No Abstract] [Full Text] [Related]
25. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
Kühnau J; Rüdiger H; Goetz K
Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of recombinant DNA human insulin.
Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ; Hufferd S
Diabetologia; 1983 Dec; 25(6):465-9. PubMed ID: 6198228
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of insulin of various origins.
Reeves WG
Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
[No Abstract] [Full Text] [Related]
28. Proinsulin-specific antibodies in human sera.
Kumar D; Miller LV
Diabetes; 1973 May; 22(5):361-6. PubMed ID: 4735545
[No Abstract] [Full Text] [Related]
29. Subpopulations of antibodies directed against evolutionarily conserved regions of the insulin molecule in insulin-treated patients.
Karlsson F; Harrison LC; Kahn CR; Itin A; Roth J
Diabetologia; 1982 Dec; 23(6):488-93. PubMed ID: 6759274
[TBL] [Abstract][Full Text] [Related]
30. [Is proinsulin contamination of commercial insulin preparations responsible for the stimulation of insulin antibodies?].
Kerp L; Steinhilber S; Kasemir H
Klin Wochenschr; 1970 Jul; 48(14):884-5. PubMed ID: 5535446
[No Abstract] [Full Text] [Related]
31. Immunologic aspects of human proinsulin therapy.
Fineberg SE; Rathbun MJ; Hufferd S; Fineberg NS; Spradlin CT; Galloway JA; Frank BH
Diabetes; 1988 Mar; 37(3):276-80. PubMed ID: 3286327
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of proinsulin-specific antibodies in diabetic patients.
Kumar D; Miller LV
Horm Metab Res; 1973 Jan; 5(1):1-3. PubMed ID: 4735948
[No Abstract] [Full Text] [Related]
33. C-peptide antibodies induced by bovine insulin therapy.
Reeves WG; Douglas CA
Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
[TBL] [Abstract][Full Text] [Related]
34. [The antigenicity of various new chromatographically purified depot insulin preparations].
Graber D; Fankhauser S
Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
[TBL] [Abstract][Full Text] [Related]
35. Exacerbation of diabetes mellitus by antibodies to exogenous insulin.
Rendell M; Hamilton RG; Drew HM; Adkinson NF
Am J Med Sci; 1981; 282(1):18-26. PubMed ID: 7270568
[TBL] [Abstract][Full Text] [Related]
36. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
Asplin CM; Hartog M; Goldie DJ
Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to proinsulin in diabetic patients treated with porcine insulin preparations.
Andersen OO
Acta Endocrinol (Copenh); 1973 Jun; 73(2):304-13. PubMed ID: 4740830
[No Abstract] [Full Text] [Related]
38. Association of specific immune response to pork and beef insulin with certain HLA-DR antigens in type 1 diabetes.
Sklenar I; Neri TM; Berger W; Erb P
Br Med J (Clin Res Ed); 1982 Nov; 285(6353):1451-3. PubMed ID: 6814597
[TBL] [Abstract][Full Text] [Related]
39. The immunogenic properties of a highly purified insulin preparation.
Manning NT; Drury MI
Ir J Med Sci; 1979 Apr; 148(4):135-9. PubMed ID: 393651
[No Abstract] [Full Text] [Related]
40. The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin.
Heding LG; Larsson Y; Ludvigsson J
Diabetologia; 1980; 19(6):511-5. PubMed ID: 7007131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
